| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8647603 | Multiple Sclerosis and Related Disorders | 2018 | 6 Pages |
Abstract
The treatment with fingolimod leads to an increase of vagal activation which persists even after 14 months of treatment. These changes did not return to baseline levels on treatment with fingolimod. Based on our data an additional at least 24Â h hour-HEM after the initiation of fingolimod therapy should be considered.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Genetics
Authors
Ruken Ãzge Akbulak, Sina C. Rosenkranz, Benjamin N. Schaeffer, Hans O. Pinnschmidt, Stephan Willems, Christoph Heesen, Boris A. Hoffmann,